Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

2.
3.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
4.

Reasons for substance use among people with mental disorders.

Thornton LK, Baker AL, Lewin TJ, Kay-Lambkin FJ, Kavanagh D, Richmond R, Kelly B, Johnson MP.

Addict Behav. 2012 Apr;37(4):427-34. doi: 10.1016/j.addbeh.2011.11.039. Epub 2011 Dec 4.

PMID:
22197045
5.
6.

Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, Sampson N, Kessler RC.

Addiction. 2010 Jun;105(6):1117-28. doi: 10.1111/j.1360-0443.2010.02902.x. Epub 2010 Mar 10.

7.

Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.

J Ment Health Policy Econ. 2009 Mar;12(1):33-46.

PMID:
19346565
8.

Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys.

Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE.

Lancet. 2007 Sep 8;370(9590):841-50.

9.

Age of onset and timing of treatment for mental and substance use disorders: implications for preventive intervention strategies and models of care.

McGorry PD, Purcell R, Goldstone S, Amminger GP.

Curr Opin Psychiatry. 2011 Jul;24(4):301-6. doi: 10.1097/YCO.0b013e3283477a09. Review.

PMID:
21532481
11.

A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders.

Drake RE, O'Neal EL, Wallach MA.

J Subst Abuse Treat. 2008 Jan;34(1):123-38. Epub 2007 Jun 15. Review.

PMID:
17574803
12.

Prevalence of co-occurring substance use and other mental disorders in the Canadian population.

Rush B, Urbanoski K, Bassani D, Castel S, Wild TC, Strike C, Kimberley D, Somers J.

Can J Psychiatry. 2008 Dec;53(12):800-9.

PMID:
19087478
13.

Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations.

Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, van Ommeren M, Yasamy MT, Ayuso-Mateos JL, Birbeck GL, Drummond C, Freeman M, Giannakopoulos P, Levav I, Obot IS, Omigbodun O, Patel V, Phillips M, Prince M, Rahimi-Movaghar A, Rahman A, Sander JW, Saunders JB, Servili C, Rangaswamy T, Unützer J, Ventevogel P, Vijayakumar L, Thornicroft G, Saxena S.

PLoS Med. 2011 Nov;8(11):e1001122. doi: 10.1371/journal.pmed.1001122. Epub 2011 Nov 15. No abstract available.

14.

A review of treatments for people with severe mental illnesses and co-occurring substance use disorders.

Drake RE, Mueser KT, Brunette MF, McHugo GJ.

Psychiatr Rehabil J. 2004 Spring;27(4):360-74. Review.

PMID:
15222148
16.

Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.

Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J.

Am J Psychiatry. 1996 Sep;153(9):1195-201.

PMID:
8780425
17.

Mental health and substance use disorders among Latino and Asian American lesbian, gay, and bisexual adults.

Cochran SD, Mays VM, Alegria M, Ortega AN, Takeuchi D.

J Consult Clin Psychol. 2007 Oct;75(5):785-94.

18.

Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.

Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD.

Clin J Pain. 2010 Jan;26(1):1-8. doi: 10.1097/AJP.0b013e3181b99f35.

19.

Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Langås AM, Malt UF, Opjordsmoen S.

BMC Psychiatry. 2011 Feb 12;11:25. doi: 10.1186/1471-244X-11-25.

20.

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR.

Schizophr Bull. 1998;24(4):589-608. Review.

PMID:
9853791

Supplemental Content

Support Center